Multiple-Dose Pharmacokinetics and Pharmacodynamics of Abacavir Alone and in Combination with Zidovudine in Human Immunodeficiency Virus-Infected Adults

著者: McDowell, James A., Lou, Yu, Symonds, William S., Stein, Daniel S.
出版事項 2000

Pharmacokinetics, Safety, and Tolerability of GS-9851, a Nucleotide Analog Polymerase Inhibitor for Hepatitis C Virus, following Single Ascending Doses in Healthy Subjects

著者: Denning, Jill, Cornpropst, Melanie, Flach, Stephen D., Berrey, Michelle M., Symonds, William T.
出版事項 2013

Safety and Pharmacokinetics of Amprenavir (141W94), a Human Immunodeficiency Virus (HIV) Type 1 Protease Inhibitor, following Oral Administration of Single Doses to HIV-Infected Ad...

著者: Sadler, Brian M., Hanson, Cynthia D., Chittick, Gregory E., Symonds, William T., Roskell, Neil S.
出版事項 1999

Single-Dose Safety and Pharmacokinetics of Amprenavir (141W94), a Human Immunodeficiency Virus Type 1 (HIV-1) Protease Inhibitor, in HIV-Infected Children

著者: Yogev, Ram, Kovacs, Andrea, Chadwick, Ellen G., Homans, James D., Lou, Yu, Symonds, William T.
出版事項 2005

Safety and Pharmacokinetics of GSK364735, a Human Immunodeficiency Virus Type 1 Integrase Inhibitor, following Single and Repeated Administration in Healthy Adult Subjects

著者: Reddy, Y. Sunila, Min, Sherene S., Borland, Julie, Song, Ivy, Lin, Jiang, Palleja, Sandra, Symonds, William T.
出版事項 2007

In Vitro-In Vivo Model for Evaluating the Antiviral Activity of Amprenavir in Combination with Ritonavir Administered at 600 and 100 Milligrams, Respectively, Every 12 Hours

著者: Preston, Sandra L., Piliero, Peter J., Bilello, John A., Stein, Daniel S., Symonds, William T., Drusano, George L.
出版事項 2003

Pharmacokinetics, Pharmacodynamics, and Tolerability of GS-9851, a Nucleotide Analog Polymerase Inhibitor, following Multiple Ascending Doses in Patients with Chronic Hepatitis C I...

著者: Lawitz, Eric, Rodriguez-Torres, Maribel, Denning, Jill M., Albanis, Efsevia, Cornpropst, Melanie, Berrey, Michelle M., Symonds, William T.
出版事項 2013

Safety and Pharmacokinetics of Abacavir (1592U89) following Oral Administration of Escalating Single Doses in Human Immunodeficiency Virus Type 1-Infected Adults

著者: Kumar, Princy N., Sweet, Donna E., McDowell, James A., Symonds, William, Lou, Yu, Hetherington, Seth, LaFon, Stephen
出版事項 1999

Safety and Single-Dose Pharmacokinetics of Abacavir (1592U89) in Human Immunodeficiency Virus Type 1-Infected Children

著者: Hughes, Walter, McDowell, James A., Shenep, Jerry, Flynn, Patricia, Kline, Mark W., Yogev, Ram, Symonds, William, Lou, Yu, Hetherington, Seth
出版事項 1999

Pharmacokinetic Interaction between Amprenavir and Clarithromycin in Healthy Male Volunteers

著者: Brophy, Donald F., Israel, Debra S., Pastor, Antonio, Gillotin, Catherine, Chittick, Greg E., Symonds, William T., Lou, Yu, Sadler, Brian M., Polk, Ron E.
出版事項 2000

Sofosbuvir with peginterferon-ribavirin for 12 weeks in previously treated patients with hepatitis C genotype 2 or 3 and cirrhosis

著者: Lawitz, Eric, Poordad, Fred, Brainard, Diana M, Hyland, Robert H, An, Di, Dvory-Sobol, Hadas, Symonds, William T, McHutchison, John G, Membreno, Fernando E
出版年 Hepatology (2015)

Pharmacokinetic Interaction between Amprenavir and Rifabutin or Rifampin in Healthy Males

著者: Polk, Ronald E., Brophy, Donald F., Israel, Debra S., Patron, Roberto, Sadler, Brian M., Chittick, Gregory E., Symonds, William T., Lou, Yu, Kristoff, Debbie, Stein, D. S.
出版事項 2001

Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection

著者: Gattu Mahanandeeshwar, Cutler Paul, Zekry Amany, Liu Chiang, Skehel Mark, Tsokanas Nikos, Griffin Philip, Dev Anouk, Symonds William T, Patel Keyur, White Ian R, Rockey Don C, Berrey Michelle M, McHutchison John G
出版事項 2007-07-01

Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection

著者: White, Ian R, Patel, Keyur, Symonds, William T, Dev, Anouk, Griffin, Philip, Tsokanas, Nikos, Skehel, Mark, Liu, Chiang, Zekry, Amany, Cutler, Paul, Gattu, Mahanandeeshwar, Rockey, Don C, Berrey, Michelle M, McHutchison, John G
出版事項 2007

Factors in AIDS Dementia Complex Trial Design: Results and Lessons from the Abacavir Trial

著者: Brew, Bruce J, Halman, Mark, Catalan, Jose, Sacktor, Ned, Price, Richard W, Brown, Steve, Atkinson, Hamp, Clifford, David B, Simpson, David, Torres, Gabriel, Hall, Colin, Power, Christopher, Marder, Karen, Arthur, Justin C. Mc, Symonds, William, Romero, Carmen
出版事項 2007

Sofosbuvir and Ribavirin for Hepatitis C in Patients with HIV-1 Coinfection

著者: Sulkowski, Mark S., Naggie, Susanna, Lalezari, Jacob, Fessel, Walford Jeffrey, Mounzer, Karam, Shuhart, Margaret, Luetkemeyer, Anne F., Asmuth, David, Gaggar, Anuj, Ni, Liyun, Svarovskaia, Evguenia, Brainard, Diana M., Symonds, William T., Subramanian, G. Mani, McHutchison, John G., Rodriguez-Torres, Maribel, Dieterich, Douglas
出版年 JAMA (2014)

Infrequent Development of Resistance in Genotype 1–6 Hepatitis C Virus–Infected Subjects Treated With Sofosbuvir in Phase 2 and 3 Clinical Trials

著者: Svarovskaia, Evguenia S., Dvory-Sobol, Hadas, Parkin, Neil, Hebner, Christy, Gontcharova, Viktoria, Martin, Ross, Ouyang, Wen, Han, Bin, Xu, Simin, Ku, Karin, Chiu, Sophia, Gane, Edward, Jacobson, Ira M., Nelson, David R., Lawitz, Eric, Wyles, David L., Bekele, Neby, Brainard, Diana, Symonds, William T., McHutchison, John G., Miller, Michael D., Mo, Hongmei
出版年 Clin Infect Dis (2014)

Efficacy of Sofosbuvir and Ribavirin for treatment of Hepatitis C Genotype-1 in an Inner City Population: Virus and Host Factors that Predict Relapse: A Randomized Controlled Trial

著者: Osinusi, Anuoluwapo, Meissner, Eric G., Lee, Yu-Jin, Bon, Dimitra, Heytens, Laura, Nelson, Amy, Sneller, Michael, Kohli, Anita, Barrett, L, Proschan, Michael, Herrmann, Eva, Shivakumar, Bhavana, Gu, Wenjuan, Kwan, Richard, Teferi, Geb, Talwani, Rohit, Silk, Rachel, Kotb, Colleen, Wroblewski, Susan, Fishbein, Dawn, Dewar, Robin, Highbarger, Helene, Zhang, Xiao, Kleiner, David, Wood, Brad J., Chavez, Jose, Symonds, William, Subramanian, Mani, McHutchison, John, Polis, Michael A., Fauci, Anthony S., Masur, Henry, Kottilil, Shyamasundaran
出版年 JAMA (2013)

Directly Acting Triple Drug Anti-HCV Therapy Induces Sustained Virologic Response with a Six Week Regimen: A Proof of Concept Phase 2a Cohort Study

著者: Kohli, Anita, Osinusi, Anuoluwapo, Sims, Zayani, Nelson, Amy, Meissner, Eric G., Barrett, Lisa L., Bon, Dimitra, Marti, Miriam M, Silk, Rachel, Kotb, Colleen, Gross, Chloe, Jolley, Tim A, Sidharthan, Sreetha, Petersen, Tess, Townsend, Kerry, Egerson, D’Andrea, Kapoor, Rama, Spurlin, Emily, Sneller, Michael, Proschan, Michael, Herrmann, Eva, Kwan, Richard, Teferi, Gebeyehu, Talwani, Rohit, Diaz, Gabbie, Kleiner, David E., Wood, Brad J., Chavez, Jose, Abbott, Stephen, Symonds, William T., Subramanian, G. Mani, Pang, Phillip S., McHutchison, John, Polis, Michael A., Fauci, Anthony S, Masur, Henry, Kottilil, Shyam
出版年 Lancet (2015)